Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk

(2011) Børge G Nordestgaard et al.   CURRENT OPINION IN LIPIDOLOGY

Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer

(2011) Samir M. Hanash et al.   Nature Reviews Clinical Oncology

C-Reactive Protein and Risk of Venous Thromboembolism in the General Population

(2010) Jeppe Zacho et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women

(2010) B. G. Nordestgaard et al.   CLINICAL CHEMISTRY

C-reactive protein and all-cause mortality--the Copenhagen City Heart Study

(2010) J. Zacho et al.   EUROPEAN HEART JOURNAL

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies

(2010) Katriina Heikkilä et al.   EUROPEAN JOURNAL OF CANCER

Inflammation and Colon Cancer

(2010) Janoš Terzić et al.   GASTROENTEROLOGY

C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization

(2010) N J Timpson et al.   INTERNATIONAL JOURNAL OF OBESITY

C-Reactive Protein and Risk of Lung Cancer

(2010) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?

(2010) Sarah C.W. Marott et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study

(2010) Kristine H. Allin et al.   JNCI-Journal of the National Cancer Institute

Elevated Preoperative C-reactive Protein Predicts Poor Cancer Specific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer

(2010) Caroline O'Dowd et al.   Journal of Thoracic Oncology

C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach

(2010) M. Dahl et al.   THORAX

Comparison of the Prognostic Value of Inflammation-Based Pathologic and Biochemical Criteria in Patients Undergoing Potentially Curative Resection for Colorectal Cancer

(2009) Campbell S. D. Roxburgh et al.   ANNALS OF SURGERY

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere

(2009) Børge G Nordestgaard   CURRENT OPINION IN LIPIDOLOGY

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer

(2009) Campbell SD Roxburgh et al.   Future Oncology

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chronic Inflammation and Breast Cancer Recurrence

(2009) Steven W. Cole   JOURNAL OF CLINICAL ONCOLOGY

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

(2009) Kristine H. Allin et al.   JOURNAL OF CLINICAL ONCOLOGY

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

(2009) Robert J. Glynn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1α are Associated with C-Reactive Protein

(2008) Alexander P. Reiner et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study

(2008) Paul M. Ridker et al.   AMERICAN JOURNAL OF HUMAN GENETICS

C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy

(2008) Soichiro Yoshida et al.   BJU INTERNATIONAL

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer

(2008) Tomasz M. Beer et al.   CANCER

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

(2008) L. A. Hefler et al.   CLINICAL CANCER RESEARCH

High-Sensitivity C-Reactive Protein and Cardiovascular Disease

(2008) I. Young et al.   CLINICAL CHEMISTRY

Immune surveillance: a balance between protumor and antitumor immunity

(2008) Suzanne Ostrand-Rosenberg   CURRENT OPINION IN GENETICS & DEVELOPMENT

C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies

(2008) Konstantinos K. Tsilidis et al.   INTERNATIONAL JOURNAL OF CANCER

C-reactive protein and coronary heart disease: a critical review

(2008) J. P. Casas et al.   JOURNAL OF INTERNAL MEDICINE

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer

(2008) Yuhki Koike et al.   JOURNAL OF SURGICAL ONCOLOGY

The cancer biomarker problem

(2008) Charles L. Sawyers   NATURE

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

(2008) Jeppe Zacho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prospective Study of High-Sensitivity C-Reactive Protein as a Determinant of Mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998

(2007) W. Koenig et al.   CLINICAL CHEMISTRY